Global ANA Testing Market to Reach US$4.9 Billion by 2032 Driven by Growing Autoimmune Burden and AI-Powered Diagnostics
Industry Experts, Inc. has unveiled a new market research report, " Anti-Nuclear Antibody (ANA) Testing - A Global Market Overview ," estimating that global revenues from ANA testing are projected to climb from US$2.1 billion in 2025 to surpass US$4.9 billion by 2032, advancing at a CAGR of 12.5% during the analysis period. The growth of the ANA testing market is being powered by rising autoimmune disease prevalence worldwide, including lupus, rheumatoid arthritis, scleroderma, and Sjogren's syndrome. Increased awareness and early screening initiatives, together with favorable reimbursement policies and government-supported diagnostic programs, are fueling test volumes. Technological innovations, such as multiplex immunoassays, automation, and AI-based interpretation, are reshaping the diagnostic landscape by improving accuracy, scalability, and clinical confidence. Furthermore, expanding applications in biomarker-based research, personalized medicine, and p...